PLX Operating Income Growth
Protalix Biotherapeutics Inc · Operating Income Growth
PLX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported183.10%period ending
PLX TTM Operating Income YoY % (-122.22% → 183.10%)
Year-over-year change
High-resolution chart · PNG
PLX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 183.1044% | |
| 327.636% | |
| -240.4136% | |
| 171.4831% | |
| 155.6442% | |
| -42.602% | |
| -62.5526% | |
| -165.5891% | |
| -219.7942% | |
| 159.2737% | |
| 180.375% | |
| 183.698% | |
| 182.3624% | |
| 26.9716% | |
| 36.3992% | |
| -36.15% | |
| -18.7966% | |
| -227.4789% | |
| -855.0554% | |
| -675.4225% | |
| -505.7253% | |
| -1,060.8163% | |
| 125.2869% | |
| 112.4842% | |
| 116.5496% | |
| 97.5116% | |
| 44.4945% | |
| 38.6819% | |
| 39.5521% | |
| 43.9625% | |
| 46.8875% | |
| 19.6137% | |
| 4.4871% | |
| -10.9746% | |
| -9.6192% | |
| -4.704% | |
| -6.6925% | |
| -21.086% | |
| -40.1056% | |
| -39.443% | |
| -25.7245% | |
| -8.4163% | |
| 6.0863% | |
| 18.4642% | |
| 12.4549% | |
| 17.2698% | |
| 7.0512% | |
| -4.1865% | |
| -2.4325% | |
| -176.7179% | |
| -122.7736% | |
| -149.7929% | |
| -92.253% | |
| 72.9895% | |
| 67.9516% | |
| 71.3906% | |
| 56.1012% | |
| -45.0937% | |
| -26.7436% | |
| -5.084% | |
| 18.5096% | |
| 23.3069% | |
| 6.2654% | |
| -55.4375% | |
| -64.441% | |
| -52.7873% | |
| -32.2618% | |
| 2.7323% | |
| -1.296% | |
| 18.2039% | |
| 5.4602% | |
| 18.0222% | |
| 6.5204% | |
| -44.4113% | |
| -47.9657% | |
| -278.6546% | |
| -385.9382% | |
| -1,029.6179% | |
| -18,421.0196% | |
| -7,653.3746% | |
| -4,744.484% | |
| -1,071.5938% | |
| 43.6566% | |
| 45.538% | |
| 37.4234% | |
| -2.9765% | |
| -12.3459% | |
| -20.6981% | |
| -11.4828% | |
| 10.769% | |
| 11.1014% | |
| 43.9477% | |
| 47.4022% | |
| 50.1795% | |
| 57.0452% | |
| 40.0734% | |
| 28.0862% | |
| 23.5564% | |
| -1.1553% | |
| -48.6054% |